Cotellic (Genentech, Inc.)


Welcome to the PulseAid listing for the Cotellic drug offered from Genentech, Inc.. This Kinase Inhibitor [EPC],Kinase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Genentech, Inc.
NON-PROPRIETARY NAME: COBIMETINIB
SUBSTANCE NAME: COBIMETINIB FUMARATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Kinase Inhibitor [EPC],Kinase Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2015-11-10
END MARKETING DATE: 0000-00-00


Cotellic HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCotellic from Genentech, Inc.
LABELER NAME: Genentech, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/1)
START MARKETING DATE: 2015-11-10
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50242-717_6b81242b-c615-4160-81c7-ee645515b29d
PRODUCT NDC: 50242-717
APPLICATION NUMBER: NDA206192

Other COBIMETINIB FUMARATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Genentech, Inc.Cotellic